Regeneron Pharmaceuticals, Inc. Stock Performance

Open $743.94	Prev. Close $742.69	Circuit Range N/A
Day Range $723.94 - $743.94	Year Range $541.23 - $858.17	Volume 22,257
Average Traded $731.56

Regeneron Pharmaceuticals, Inc. Share Price Today

As of 9 October 2026, Regeneron Pharmaceuticals, Inc.'s share price is $735.63. The stock opened at $743.94, compared to its previous close of $742.69. During today's trading session, Regeneron Pharmaceuticals, Inc.'s share price traded between $723.94 and $743.94, with an average price of $733.94. Over the past 52 weeks, the stock has recorded a high of $858.17 and a low of $541.23. In terms of performance, Regeneron Pharmaceuticals, Inc.'s share price has risen by 4.03% over the last six months and is up 12.90% on a year-on-year basis.

Regeneron Pharmaceuticals, Inc. Share Price Chart

$723.94$743.94

Regeneron Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap $76.95B	PE Ratio (TTM) 17.65	Dividend Yield 0.50%
EPS (TTM) $42.04	Revenue (TTM) $14.34B	Return On Equity (TTM) 13.65%
Profit Margin 31.38%	Debt to Equity 0.09	Quarterly Earnings Growth YoY -11.17%

Regeneron Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$3754.30	$3884.30	$3605.40	$4290.70
Net Profit	$1460.00	$844.60	$727.20	$1296.90
Net Profit Margin	38.89%	21.74%	20.17%	30.23%
Income Change	N/A	-42.15%	-13.90%	78.34%

Regeneron Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$12.17	$13.12	$14.20	$14.34
Net Profit	$4.34	$3.95	$4.41	$4.50
Net Profit Margin	35.66%	30.11%	31.06%	31.38%
Income Change	N/A	-8.99%	11.65%	2.04%

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Regeneron Pharmaceuticals, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$764.75	$735.94	-3.03%
Sep 2026	$805.30	$758.94	-6.03%
Aug 2026	$769.52	$807.67	+5.89%
Jul 2026	$629.90	$762.72	+22.33%
Jun 2026	$608.49	$623.51	+1.79%
May 2026	$702.85	$612.54	-13.37%
Apr 2026	$775.78	$707.12	-8.44%
Mar 2026	$772.50	$772.33	-1.17%
Feb 2026	$734.75	$781.47	+5.38%
Jan 2026	$772.51	$741.55	-3.93%
Dec 2025	$775.60	$771.86	-1.09%
Nov 2025	$654.75	$780.34	+19.76%

REGN Share Price FAQs

What is Regeneron Pharmaceuticals, Inc. share price today?

Regeneron Pharmaceuticals, Inc. share price today is $735.63 as on October 9, 2026 at 12:27 am IST.

What is the 52 week high and 52 week low of Regeneron Pharmaceuticals, Inc. stock?

The 52 week high of Regeneron Pharmaceuticals, Inc. stock is $858.17, while the 52 week low is $541.23 as of 9 Oct '26.

What is REGN's market capitalisation today?

REGN market capitalisation is $76.95B as of October 9, 2026, at 12:27 am IST.

What is REGN's net income for the last quarter?

REGN's net income for the last quarter is 1296.90B USD.

What is the 5 year returns of REGN?

The 5 year returns of REGN is 14.95% as on 9 Oct '26.

What is the high & low stock price of REGN today?

REGN stock price hit a high of $743.94 and low of $723.94 as of 9 Oct '26.

Can I buy REGN shares in India?

Yes. You can buy REGN in India by opening an international trading account.